| scholarly article | Q13442814 |
| P2093 | author name string | Sandra T Davidge | |
| Lesley J Brennan | |||
| Jude S Morton | |||
| P2860 | cites work | Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1 | Q57105968 |
| Relationship between maternal serum vascular endothelial growth factor concentration in early pregnancy and fetal and placental growth | Q57273839 | ||
| Endothelial Progenitor Cell Dysfunction: A Novel Concept in the Pathogenesis of Vascular Complications of Type 1 Diabetes | Q57790499 | ||
| In Preeclampsia, the Circulating Factors Capable of Altering In Vitro Endothelial Function Precede Clinical Disease | Q58035998 | ||
| Vascular Endothelial Growth Factor Is Induced by the Inflammatory Cytokines Interleukin-6 and Oncostatin M in Human Adipose Tissue In Vitro and in Murine Adipose Tissue In Vivo | Q58071389 | ||
| Hydrogen peroxide mediates the cell growth and transformation caused by the mitogenic oxidase Nox1 | Q24291189 | ||
| Interleukin 6 induces the expression of vascular endothelial growth factor | Q24316308 | ||
| The biology of VEGF and its receptors | Q27860704 | ||
| A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies | Q28239787 | ||
| Soluble endoglin contributes to the pathogenesis of preeclampsia | Q28244053 | ||
| Circulating endothelial progenitor cells and cardiovascular outcomes | Q28271167 | ||
| The NADPH oxidase NOX4 drives cardiac differentiation: Role in regulating cardiac transcription factors and MAP kinase activation | Q28510993 | ||
| Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele | Q29547733 | ||
| Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia | Q29615916 | ||
| Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis | Q29617644 | ||
| Molecular mechanisms of preeclampsia | Q33344105 | ||
| Recombinant vascular endothelial growth factor 121 infusion lowers blood pressure and improves renal function in rats with placentalischemia-induced hypertension | Q33666742 | ||
| Maternal endothelial progenitor colony-forming units with macrophage characteristics are reduced in preeclampsia | Q33698023 | ||
| Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array | Q33761815 | ||
| Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor | Q33848380 | ||
| Maternal circulating CD34+VEGFR-2+ and CD133+VEGFR-2+ progenitor cells increase during normal pregnancy but are reduced in women with preeclampsia | Q33945532 | ||
| Placental growth factor is a potent vasodilator of rat and human resistance arteries. | Q34052025 | ||
| Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses | Q34897462 | ||
| Arginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsia | Q34997667 | ||
| Low Levels of Hydrogen Peroxide Stimulate Corneal Epithelial Cell Adhesion, Migration, and Wound Healing | Q35005956 | ||
| Hypertension in response to placental ischemia during pregnancy: role of B lymphocytes | Q35029700 | ||
| Excessive stimulation of poly(ADP-ribosyl)ation contributes to endothelial dysfunction in pre-eclampsia | Q35048713 | ||
| Diagnosis and management of gestational hypertension and preeclampsia | Q35173115 | ||
| Angiotensin II type 1 autoantibody induced hypertension during pregnancy is associated with renal endothelial dysfunction | Q35576417 | ||
| Autoantibody from women with preeclampsia induces soluble Fms-like tyrosine kinase-1 production via angiotensin type 1 receptor and calcineurin/nuclear factor of activated T-cells signaling | Q35681804 | ||
| Active participation of endothelial cells in inflammation | Q35998467 | ||
| The biology of vascular endothelial growth factors. | Q36017169 | ||
| Contribution of PARP to endothelial dysfunction and hypertension in a rat model of pre-eclampsia. | Q36110513 | ||
| A model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) model | Q36115311 | ||
| Characterization of the increase in vascular permeability induced by vascular permeability factor in vivo | Q36329395 | ||
| Tumor necrosis factor-mediated release of platelet-derived growth factor from cultured endothelial cells | Q36353693 | ||
| Preeclampsia: current understanding of the molecular basis of vascular dysfunction | Q36378380 | ||
| The effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancy | Q36407259 | ||
| Inflammation and pre-eclampsia | Q36530771 | ||
| The role of the immune system in preeclampsia | Q36791219 | ||
| Expectant management of severe preeclampsia remote from term: patient selection, treatment, and delivery indications | Q36839997 | ||
| Plasma interleukin-12 is elevated in patients with preeclampsia | Q36897342 | ||
| Hypertension in pregnancy: an emerging risk factor for cardiovascular disease | Q36980294 | ||
| A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a sma | Q36984261 | ||
| Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction | Q37022723 | ||
| Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test? | Q37172647 | ||
| Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype. One cause of defective endovascular invasion in this syndrome? | Q37366512 | ||
| Vascular permeability factor (vascular endothelial growth factor) gene is expressed differentially in normal tissues, macrophages, and tumors | Q37370535 | ||
| Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries | Q37377640 | ||
| Autoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant rats | Q37436219 | ||
| Hypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1. | Q37447371 | ||
| The global impact of pre-eclampsia and eclampsia | Q37493240 | ||
| Endothelial progenitor cells: their potential in the placental vasculature and related complications | Q37633745 | ||
| Immunologic characteristics of preeclampsia, a comprehensive review | Q37786350 | ||
| Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: an implication for the placental vascular development and the pathophysiology of preeclampsia | Q40530224 | ||
| Preeclampsia: an excessive maternal inflammatory response to pregnancy | Q40824430 | ||
| Regulation of vascular endothelial growth factor expression by insulin-like growth factor I. | Q41089071 | ||
| Preeclampsia: an endothelial cell disorder | Q41281924 | ||
| Vascular endothelial growth factor stimulates prostacyclin production and activation of cytosolic phospholipase A2 in endothelial cells via p42/p44 mitogen-activated protein kinase | Q42450205 | ||
| Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life | Q42483273 | ||
| Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kappaB. | Q42536078 | ||
| Diverse mechanisms of endothelium-derived hyperpolarizing factor-mediated dilatation in small myometrial arteries in normal human pregnancy and preeclampsia | Q42976875 | ||
| Association of maternal endothelial dysfunction with preeclampsia | Q43553727 | ||
| Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease | Q43664648 | ||
| Matrix metalloproteinase enhances big-endothelin-1 constriction in mesenteric vessels of pregnant rats with reduced uterine blood flow | Q43787822 | ||
| Expression of vascular endothelial growth factor (VEGF) and its receptors in human endometrium throughout the menstrual cycle and in early pregnancy | Q43907829 | ||
| Low-salt diet enhances vascular reactivity and Ca(2+) entry in pregnant rats with normal and reduced uterine perfusion pressure | Q43908186 | ||
| Autoantibody against AT1 receptor from preeclamptic patients induces vasoconstriction through angiotensin receptor activation | Q44218760 | ||
| AT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidase | Q44385661 | ||
| Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia | Q44414984 | ||
| Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia | Q44434565 | ||
| Endothelial dysfunction in preeclampsia. Increased homocysteine and decreased nitric oxide levels | Q44653521 | ||
| Vascular dysfunction and reduced circulating endothelial progenitor cells in young healthy UK South Asian men. | Q44670183 | ||
| The imbalance between thromboxane and prostacyclin in preeclampsia is associated with an imbalance between lipid peroxides and vitamin E in maternal blood | Q44929427 | ||
| Reduced uteroplacental perfusion alters uterine arcuate artery function in the pregnant Sprague-Dawley rat. | Q45163173 | ||
| Circulating endothelial progenitor cells during human pregnancy | Q45178368 | ||
| Plasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterization. | Q45947357 | ||
| Increased lectin-like oxidized low-density lipoprotein receptor-1 expression in the maternal vasculature of women with preeclampsia: role for peroxynitrite | Q46185680 | ||
| Preeclamptic Sera Stimulate Increased Platelet-Derived Growth Factor mRNA and Protein Expression by Cultured Human Endothelial Cells | Q46190634 | ||
| Quantitative analysis of trophoblast invasion in preeclampsia | Q46211995 | ||
| Thrombomodulin, plasminogen activator inhibitor type 1 (PAI-1) and fibronectin as biomarkers of endothelial damage in preeclampsia and eclampsia | Q46305789 | ||
| Lectin-like oxidized low-density lipoprotein 1 receptor in a reduced uteroplacental perfusion pressure rat model of preeclampsia | Q46324781 | ||
| Maternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretion | Q46344658 | ||
| Endothelium-derived hyperpolarizing factor in preeclampsia: heterogeneous contribution, mechanisms, and morphological prerequisites | Q46886600 | ||
| Circulating angiogenic factors and the risk of preeclampsia | Q47217679 | ||
| Sequential expression of VEGF and its receptors in human placental villi during very early pregnancy: differences between placental vasculogenesis and angiogenesis. | Q47626896 | ||
| A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy | Q47996271 | ||
| Haemodynamics in women with untreated pre-eclampsia | Q48152316 | ||
| Decreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant rat. | Q50514586 | ||
| Concentration of circulating endothelial progenitor cells (EPC) in normal pregnancy and in pregnant women with diabetes and hypertension. | Q50774930 | ||
| The relationship of the level of circulating antiangiogenic factors to the clinical manifestations of preeclampsia. | Q51799630 | ||
| Impairment of endothelial function in women with a history of preeclampsia: an indicator of cardiovascular risk. | Q51942463 | ||
| Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. | Q53600812 | ||
| Decrease and senescence of endothelial progenitor cells in patients with preeclampsia. | Q53670880 | ||
| Differential blood flow in uterine, ophthalmic, and brachial arteries of preeclamptic women. | Q53950981 | ||
| Longitudinal evaluation of predictive value for preeclampsia of circulating angiogenic factors through pregnancy. | Q54483574 | ||
| Tumor necrosis factor-alpha induces endothelial dysfunction in Lepr(db) mice. | Q54564514 | ||
| The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia. | Q54599986 | ||
| Pre-eclampsia | Q56019568 | ||
| Elevated Serum Soluble Vascular Endothelial Growth Factor Receptor 1 (sVEGFR-1) Levels in Women with Preeclampsia | Q56619500 | ||
| Reactive Oxygen Species Regulate Activation-Induced T Cell Apoptosis | Q56922123 | ||
| Agonistic Angiotensin II Type 1 Receptor Autoantibodies in Postpartum Women With a History of Preeclampsia | Q56981931 | ||
| P433 | issue | 1 | |
| P921 | main subject | maternal health | Q6786626 |
| pre-eclampsia | Q61335 | ||
| P304 | page(s) | 4-14 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | Microcirculation | Q15764357 |
| P1476 | title | Vascular dysfunction in preeclampsia | |
| P478 | volume | 21 |
| Q38896215 | 67-kDa Laminin receptor contributes to hypoxia-induced migration and invasion of trophoblast-like cells by mediating matrix metalloproteinase-9. |
| Q28069689 | A Dormant Microbial Component in the Development of Preeclampsia |
| Q33761525 | A novel mechanism of angiotensin II-regulated placental vascular tone in the development of hypertension in preeclampsia |
| Q58737878 | Apolipoprotein A1 mimetic peptide ATI-5261 reverses arterial stiffness at late pregnancy and early postpartum in a COMT mouse model of preeclampsia |
| Q33620530 | Associations of adherence to the New Nordic Diet with risk of preeclampsia and preterm delivery in the Norwegian Mother and Child Cohort Study (MoBa) |
| Q48067235 | Brain Structural and Vascular Anatomy Is Altered in Offspring of Pre-Eclamptic Pregnancies: A Pilot Study |
| Q47688833 | Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia |
| Q60047012 | Crosstalk Between Nitric Oxide and Endocannabinoid Signaling Pathways in Normal and Pathological Placentation |
| Q90683764 | Differences in expression of Peroxisome Proliferator-activated Receptor-γ in early-onset preeclampsia and late-onset preeclampsia |
| Q64118718 | Downregulation of lysyl oxidase and lysyl oxidase-like protein 2 suppressed the migration and invasion of trophoblasts by activating the TGF-β/collagen pathway in preeclampsia |
| Q51027700 | Effect of sodium tanshinone IIA sulfonate treatment in a rat model of preeclampsia. |
| Q46203952 | Effects of haemoglobin levels on the sublingual microcirculation in pregnant women |
| Q36176901 | Emergence of a metalloproteinase / phospholipase A2 axis of systemic inflammation |
| Q36464599 | Endocan of the maternal placenta tissue is increased in pre-eclampsia |
| Q89161381 | Hypertensive Disorders of Pregnancy and Cardiovascular Diseases: Current Knowledge and Future Directions |
| Q40111116 | Immune activation during the implantation phase causes preeclampsia-like symptoms via the CD40-CD40 ligand pathway in pregnant mice |
| Q36381293 | Impaired neurovascular reactivity in the microvasculature of pregnant women with preeclampsia. |
| Q51347127 | Lower placental growth factor and higher free β-hCG and PAPP-A levels in the fetal circulation of near-term pregnancies complicated with severe preeclampsia. |
| Q46342648 | Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia |
| Q89763980 | Mechanisms linking exposure to preeclampsia in utero and the risk for cardiovascular disease |
| Q37136212 | Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia |
| Q55334091 | Oxidative Stress in Preeclampsia and Placental Diseases. |
| Q98177261 | Placental hypoxia-induced alterations in vascular function, morphology, and endothelial barrier integrity |
| Q88542480 | Placental ischemia-stimulated T-helper 17 cells induce preeclampsia-associated cytolytic natural killer cells during pregnancy |
| Q41834849 | Plasma from pre-eclamptic patients induces the expression of the anti-angiogenic miR-195-5p in endothelial cells. |
| Q36141421 | Postpartum Vascular Dysfunction in the Reduced Uteroplacental Perfusion Model of Preeclampsia |
| Q58605354 | Pre-eclampsia and risk of dementia later in life: nationwide cohort study |
| Q26800272 | Preeclampsia: long-term consequences for vascular health |
| Q55348041 | Recent Advances in Placenta–Heart Interactions. |
| Q40322864 | Reduced uterine perfusion pressure decreases functional capillary density in skeletal muscle |
| Q46586252 | Relaxin deficiency attenuates pregnancy-induced adaptation of the mesenteric artery to angiotensin II in mice. |
| Q33944749 | Role of lectin-like oxidized low density lipoprotein-1 in fetoplacental vascular dysfunction in preeclampsia |
| Q57165680 | The effect of pre-eclampsia on retinal microvascular caliber at delivery and post-partum |
| Q28392163 | Uterine microvascular sensitivity to nanomaterial inhalation: An in vivo assessment |
Search more.